Shree Ganesh Remedies enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026FY25Mar 2025FY24Mar 2024
845———
25.825.828.220.4
30.730.738.236.3
850———
4.94.910.115.9
₹661.78———
194194183158
15.8%15.8%20.8%22.9%
0.04×———
7.78×———
24.27×———
34.62×———
35.78×———
35.78×———
Reference items — trailing FY values
109109109126
35.035.039.241.8
24.524.529.635.7
23.823.830.7—
23.823.830.7—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SGRL₹658.00

Shree Ganesh Remedies Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSHUKRAPHARSUNLOCMcap ₹845 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
Market Capitalization———845.0
- Cash, Equiv & ST Investments20.428.225.825.8
+ Total Debt36.338.230.730.7
Enterprise Value———849.9
Net Debt (memo)15.910.14.94.9
EV per Share———661.78
Total Capital158.4183.4193.7193.7
Total Debt/Total Capital22.9220.8515.8415.84
Total Debt/EV———0.04
EV/Sales———7.78
EV/EBITDA———24.27
EV/EBIT———34.62
EV/Operating Cash Flow———35.78
EV/Free Cash Flow———35.78
Reference Items — Trailing FY Values
Sales125.9108.6109.3109.3
EBITDA41.839.235.035.0
EBIT35.729.624.524.5
Operating Cash Flow—30.723.823.8
Free Cash Flow—30.723.823.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.